Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lobaplatin vs cisplatin chemoradiotherapy for cervical cancer
ChiCTR2000035449Phase 3Not yet recruiting
- Sponsor
- Shanghai Sixth People's Hospital
- Start
- Aug 2020
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of lobaplatin in Cervical Cancer (CC) (2 arms), sponsored by Shanghai Sixth People's Hospital. Primary endpoint: Renal function. Planned start Aug 2020; status: not yet recruiting.
02
Drugs
lobaplatin
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on ChiCTR2000035449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000035449.